HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing (Cosmetics)

Product Launches

Set Alert for Product Launches (Beauty)

Latest From Beauty & Launches

NOYZ Intends To Be Heard At Ulta Beauty This Summer

“In an industry that has long been rooted in hyper-filtered fantasy, we saw a massive white space in the fragrance market for a brand rooted in realism,” says NOYZ creator Shaun Neff. The brand is part of a newness infusion aimed at driving Ulta growth amid a broad-based prestige beauty slowdown.

Retail Advertising, Marketing & Sales

Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs

Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L sees in dry eye product category. Consumer eye care and vision health product sales are key drivers for 18% Q1 net sales growth to $1.1bn.

Consumer Sales & Earnings

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches
See All

Cosmetic Ingredients

Set Alert for Cosmetic Ingredients (Beauty)

Latest From Beauty & Cosmetic Ingredients

California Court Delivers ‘Win’ For Cosmetics Companies In Prop 65 TiO2 Case

Proposition 65 titanium dioxide lawsuits have been halted by a ruling in California in a First Amendment case, which could bode favorably for other scientific challenges to mandated warning labels.

Legal Issues Cosmetic Ingredients

Drug/Cosmetic Uncertainty Clouds CIR Panel Review Of Prostaglandin Analogs

Cosmetic Ingredient Review’s independent expert panel needs more data to assess the safety of prostaglandin analogs, but ultimately may pass review back to the US Food and Drug Administration due to concerns that the substances impact the structure and function of the body and thus are unapproved drugs with potentially serious side effects.

Cosmetic Ingredients Safety

Formaldehyde Hair-Smoothing Ban Still ‘High Priority’ For US FDA Despite Proposed Rule Delay

Amid organizational and leadership changes and numerous competing high priorities, the FDA’s planned Notice of Proposed Rulemaking to ban formaldehyde-containing hair-straightening products has been pushed from April to July 2024. An agency spokesperson provided an update on related activities, which are being closely watched by NGOs, state-level policymakers, and industry stakeholders.

FDA Regulation
See All

Advertising Campaigns

Set Alert for Advertising Campaigns(Beauty)

Latest From Beauty & Ad Campaigns

CARU Puts Brands On Notice: Guidelines For Children’s Advertising Extend To AI

The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.

US States Beauty

Perrigo Partnership Makes Opill Star Player On WNBA's Reproductive Health Advocacy Team

Less than a month into launching sales of first oral contraceptive approved for US OTC sales, Perrigo announces multi-year partnership with WNBA focused on building confidence, strength and health equity for women.

Ad Campaigns Prescription To OTC Switch

EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine

Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive. 

Europe Health
See All

Advertising Complaints

Set Alert for Advertising Complaints (Beauty)

Latest From Beauty & Ad Complaints

MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance

FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.

Ad Complaints Consumer

EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine

Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive. 

Europe Health

Take Care With ‘Health Lite’ Claims

Some advertisers try to avoid scrutiny of regulators and the National Advertising Division when making health-related claims by making a claim “softer.” Annie Ugurlayan, NAD’s assistant director, offers advice on assuring substantiation and a health claim match.

Ad Complaints Dietary Supplements
See All
UsernamePublicRestriction

Register